Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials episode artwork

EPISODE · Nov 2, 2023 · 24 MIN

Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials

from BUILDERS · host Front Lines Media

In today's episode of Category Visionaries, we speak with Kourosh Davarpanah, Co-Founder and CEO of Inato, a global clinical trial platform that's raised over $35 Million in funding. Topics Discussed: Kourosh’s background coming from a family of doctors, fainting on the sight of blood, and being passionate about math and physics Why Kourosh finds Airbnb inspiring  How less than 5% of the patient population have access to clinical trials, why this is a problem, and how Inato helps pharma companies coordinate with hospitals to offer the right trials to their patients The chicken-and-egg problem of marketplace platforms, and how Kourosh dealt with it How to build credibility, and the danger of overfitting when working with only one client   Favorite book:  Complexity: The Emerging Science at the Edge of Order and Chaos

Episode metadata supplied by the publisher feed · Published Nov 2, 2023

Embed this episode

Ready to play

Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials

0:00 24:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of BUILDERS?

This episode is 24 minutes long.

When was this BUILDERS episode published?

This episode was published on November 2, 2023.

Can I download this BUILDERS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!